Plain-English translation of NCT06646471 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This is a research study that follows older adults (70 and over) who have been diagnosed with non-small cell lung cancer and are starting treatment. The study collects real-world information about how well treatments work, what side effects patients experience, and how the cancer journey affects their daily life and well-being. Researchers will use this information to better understand how to treat lung cancer in older patients.
Most clinical research focuses on younger, healthier patients, but older adults with lung cancer often face unique challenges and may not tolerate treatments the same way. This study exists to gather real-world data about how standard and newer treatments actually perform in older patients, so doctors can make better, more personalized treatment decisions for this age group.
You likely qualify if…
You likely don't qualify if…
You would continue receiving your regular cancer treatment at the hospital as usual, visiting your doctor for normal checkups and tests. In addition, you would be asked to provide blood samples for research, complete regular quality-of-life questionnaires (brief surveys about how you're feeling and managing), and undergo a few additional tests specific to older adults' health. The study follows your progress over time as determined by your doctor's regular clinical practice.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
France